Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Retaining Talent Will Be The Largest Priority for Hospitals for the Foreseeable Future

In many industries, including healthcare, staffing shortages and the challenges related to retaining and attracting top talent have become a major topic. David Kemp, host of Highway to Health spoke with Laurence Kessler, Senior Vice President of Growth and Partnerships at Healthrise on the matter. The challenges with staffing have provided a major problem for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In many industries, including healthcare, staffing shortages and the challenges related to retaining and attracting top talent have become a major topic. David Kemp, host of Highway to Health spoke with Laurence Kessler, Senior Vice President of Growth and Partnerships at Healthrise on the matter.

The challenges with staffing have provided a major problem for hospitals and caregivers in the healthcare space. “Nurses and clinicians are becoming travel nurses because they are making more money elsewhere and CFOs are way over budget because they are looking outside for agency nurses,” Kessler said.

Kessler, who has an extensive background in healthcare digs further, “looking back, healthcare as an industry, we are behind compared to other industries in terms of technology, there is so much opportunity out there in the public health component,” he said.

But companies like Healthrise, they’re in the business of being problem solvers, “we’ve developed a staffing solution to provide the resources. We also have business office capabilities to help come in and work segments, but what’s cool is our new tool, demand workforce which is an app base solution that helps you fill in the nursing shifts with existing staff before you have to go look outside,” Kessler said. “We are filling 50% of shifts within 5 to 7 minutes.”

In the future Kessler hopes to see leaps in automation, “we are going to get better, we are going to be more efficient and figure out what functions can be automated going forward, so we can do more with less. It’s going to help solve staffing solutions and provide employees with more satisfaction,” he said.

More Like This Story:

How Josh Byrd Uses Songwriting Experience to Tell the Patient Story

Big Tech is Helping Healthcare Organizations Recover Profit Loss

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512